Sales Nexus CRM

Nanox Builds Integrated Imaging Ecosystem to Tackle Global Access Gap

By Advos•
Nanox is assembling an integrated imaging platform to expand access to 3D imaging and diagnostics in underserved markets, where roughly two-thirds of the world's population lacks basic imaging technology.
Nanox Builds Integrated Imaging Ecosystem to Tackle Global Access Gap

Advanced medical imaging has transformed diagnosis, yet access remains uneven. Roughly two-thirds of the world's population lacks access to basic imaging technology, and the radiologist workforce gap is stark: an estimated 1.9 radiologists per million people in low-income countries versus 97.9 per million in high-income countries. Access challenges also persist in developed markets, where geography, cost and infrastructure determine where advanced imaging can economically operate.

Nano-X Imaging Ltd. (NASDAQ: NNOX) is approaching that problem from a different direction. Rather than building another high-end system for major hospitals, Nanox is assembling an integrated platform intended to extend medical imaging into outpatient facilities, clinics and other settings where conventional advanced imaging infrastructure is difficult to justify.

At the center of the platform is Nanox.ARC, an FDA-cleared multi-source digital tomosynthesis system built around the company's proprietary digital X-ray source technology. The system is designed to produce 3D tomosynthesis images and support advanced imaging in a range of clinical environments, while Nanox continues to emphasize lower barriers to adoption through Read More>>.

Nanox brings together Nanox.ARC, Nanox.AI, Nanox.CLOUD, Nanox.MARKETPLACE, USARAD Holdings and Nanox Health IT as part of its broader imaging ecosystem. Commercial activity is beginning to build, with second-quarter revenue of $4.2 million.

The importance of this development lies in its potential to address a global health inequity. By integrating AI, cloud and marketplace capabilities, Nanox aims to make advanced imaging more accessible and affordable. If successful, this could improve early diagnosis and treatment in regions that currently lack adequate imaging services, while also creating new opportunities in developed markets where cost and infrastructure limit access.

For investors, the latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. The announcement was distributed through MissionIR, a communications platform within the Dynamic Brand Portfolio at IBN. MissionIR provides access to wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and tailored corporate communications solutions. For more information, visit www.MissionIR.com.

Advos

Advos

@advos